Ali Aminian, ESC 2021 – Obesity and COVID-19
Dr Ali Aminian (Director, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH, USA) kindly shared his thoughts on the association between obesity and COVID-19 and the results of his study on the association of prior metabolic surgery and bariatric surgery with COVID-19 severity from the virtual ESC Congress 2021. Questions What have we learned about […]
Darryl Leong, ESC 2021 – Cardiometabolic Risk Factors and COVID-19
Dr Darryl Leong (Cardiologist, The Population Health Research Institute, McMaster University, Hamilton, ON, Canada) kindly shared his thoughts on the association between cardiometabolic risk factors and COVID-19 outcomes from the virtual ESC Congress 2021. Questions What has recent data taught us about the association between cardiometabolic risk factors and COVID-19 outcomes? (0.15) On the basis […]
Gilles Montalescot, ESC 2021 – the QUORUM Clinical Study
Prof. Gilles Montalescot (Professor, Pitié-Salpêtrière Hospital, Paris, France) kindly shared his thoughts on the difficulty of treating heart failure after acute myocardial infarction, the use of firibastat and the QUORUM clinical study (NCT03715998) from the virtual ESC Congress 2021. Questions Why does heart failure after acute myocardial infarction remain so challenging to treat? (0.19) Could […]
Trudie Lobban, HRC 2021 – the A-A Heart Rhythm Congress 2021
Trudie Lobban (Founder and Trustee of the Arrhythmia Alliance, Chair of the HRC Organising Committee) introduces the A-A Heart Rhythm Congress 2021 (launching 3rd October 2021) and provides an overview of what to expect from this year’s meeting, why healthcare professionals should register, who can attend, and why the virtual platform will make this the […]
COVID-19 and Cardiac Arrhythmias
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):33-39 DOI: https://doi.org/10.17925/EJAE.2021.7.1.33
The current outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has developed into a worldwide pandemic affecting millions of lives in one way or another.1 Over the period of 1 year since the disease was first reported from Wuhan, China,2 COVID-19 has infected over 50 million patients and resulted […]
Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease
Heart International. 2021;15(1):14-19 DOI: https://doi.org/10.17925/HI.2021.15.1.14
Peripheral artery disease (PAD) is a severe manifestation of systemic atherosclerotic disease that commonly refers to lower-extremity arterial involvement. The global burden of PAD is estimated to involve over 200 million patients, with prevalence increasing by 24% over the past decade.1 In contrast to myocardial infarction and stroke, which are declining in the USA, the […]
Dual Antiplatelet Therapy in Patients with High Cardiovascular Risk
Heart International. 2021;15(1):26-36 DOI: https://doi.org/10.17925/HI.2021.15.1.26
Coronary artery disease (CAD) is encountered on a daily basis in the field of medicine. Between 2009 and 2012, the global prevalence of CAD was 154 million, based on data from the Global Burden of Disease study; for the same period in the USA, it was approximately 15.5 million, based on data collected by the […]
The Role of Rilonacept in Recurrent Pericarditis
Heart International. 2021;15(1):20-25 DOI: https://doi.org/10.17925/HI.2021.15.1.20
Pericarditis is the most common form of pericardial disease, with an incidence of 27.7 cases per 100,000 population per year.1 Approximately 15–30% of patients with acute pericarditis will have a first recurrence within 18 months despite optimal medical therapy. Half of these patients will fail to achieve complete remission and will continue to have recurrent […]
Click here to view more medical education and communication. This content is sponsored by the pharmaceutical industry and developed by TMC.
3/Obstructive sleep apnoea, obesity and atrial fibrillation: a Mendelian randomisation study
European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr3
Aims: The association between obstructive sleep apnoea (OSA) and atrial fibrillation (AF) is yet to be fully delineated. Although several observational studies have suggested an independent association between OSA and AF, subsequent randomised controlled trials have failed to demonstrate any benefit of OSA treatment on reducing AF incidence. Complicating the interpretation of the data on […]
58/Assessing the overall impact of using conscious sedation for performing external cardioversion
European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr58
Introduction: Direct Current Cardioversion (DCC) is one of the most effective means of converting atrial fibrillation into sinus rhythm. This is often chosen over medical cardioversion due to its shorter overall procedure duration, high success rate and low risk of proarrhythmias. It is indicated in haemodynamically unstable patients and stable patients who are unlikely to […]
6/A hub-and-spoke model implementing HeartLogic in cardiac device patients across east London and beyond
European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr6
Introduction: The HeartLogic (HL) index (Boston Scientific) is a novel multisensory approach in the monitoring of heart failure (HF) patients with ResonateTM cardiac defibrillator devices. Without a dedicated HF nurse team onsite at St Bartholomew’s Hospital, and the subsequent COVID-19 pandemic, it has been vital to liaise with patients’ local community care teams to reduce […]
36/Elimination of major vascular access complications (VAC) using ultrasound-guided vascular access and vessel closure protocols during Invasive EP procedures (IEPP)
European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr36
Introduction: Vascular access complications (VAC) are common complications associated with invasive electrophysiology procedures (IEPP) and can lead to significant morbidity and mortality. Reducing the risk of VAC is of considerable interest to Electrophysiologists. We studied the impact of vascular access and vessel closure protocols utilizing ultrasound-guided vascular access (UG) on the incidence of IEPP associated […]
Want To Know More About Our Journals?
Taking a balanced and practical view of the current clinical landscape in Cardio is at the heart of touchCARDIO and the journals we produce.
The European Journal of Arrhythmia & Electrophysiology and Heart International are double-blind peer reviewed by at least two independent experts in the field to ensure articles are balanced, objective and relevant to the day-to-day clinical setting.
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!